Love Hemp Group Plc (WRHLF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Love Hemp Group Plc (WRHLF) with AI Score 59/100 (Hold). Love Hemp Group Plc operates as a private equity and venture capital firm, focusing on early-stage and mature companies within the Cannabidiol (CBD) wellness and medicinal cannabis sectors. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Love Hemp Group Plc (WRHLF) Healthcare & Pipeline Overview
Love Hemp Group Plc is a private equity and venture capital firm specializing in the burgeoning CBD wellness and medicinal cannabis sectors, investing in early-stage and mature companies across diverse geographies. The firm's focus spans cultivation, manufacturing, and distribution of CBD products, positioning it within the rapidly evolving healthcare landscape.
Investment Thesis
Love Hemp Group Plc presents an investment opportunity within the expanding CBD wellness and medicinal cannabis market. The company's strategy of acquiring stakes in early-stage and mature businesses across the value chain, from cultivation to distribution, positions it to capitalize on the industry's growth. Key value drivers include the increasing acceptance and legalization of CBD products globally, driving demand for Love Hemp's portfolio companies. The company's focus on diverse geographies, including Europe, North America, and Asia, mitigates regulatory risks and provides access to multiple markets. However, the company's negative profit margin of -99.9% and the inherent risks associated with the OTC market necessitate careful consideration. A potential catalyst is the further deregulation of cannabis and CBD products in key markets, which could significantly boost revenue for its portfolio companies. The company's success hinges on its ability to identify and nurture promising ventures within the evolving cannabis landscape.
Based on FMP financials and quantitative analysis
Key Highlights
- Love Hemp Group Plc operates with a lean team of 28 employees, reflecting its focus on strategic investments rather than large-scale operations.
- The company's gross margin of 28.9% indicates potential for profitability in its portfolio companies, although this is offset by a significant negative profit margin.
- Love Hemp Group Plc's beta of 1.78 suggests higher volatility compared to the overall market, typical for companies in emerging sectors.
- The company's investments span across Europe, North America and Asia, providing geographical diversification.
- Love Hemp Group Plc's focus on the CBD wellness and medicinal cannabis sectors aligns with growing consumer interest and market expansion in these areas.
Competitors & Peers
Strengths
- Specialized focus on the high-growth CBD and medicinal cannabis sectors.
- Diversified investment approach across the value chain.
- Global presence with investments in multiple regions.
- Experienced management team with expertise in private equity and venture capital.
Weaknesses
- Negative profit margin indicates potential financial instability.
- Limited operating history as the company was founded in 2019.
- Small team size may limit the company's ability to manage multiple investments.
- Dependence on the regulatory environment for cannabis and CBD products.
Catalysts
- Potential deregulation of cannabis and CBD products in key markets could significantly boost revenue for its portfolio companies.
- Increasing consumer demand for CBD wellness products driving growth in the sector.
- Strategic partnerships with established companies in the healthcare and retail sectors could expand market reach.
Risks
- Regulatory uncertainty and changing laws regarding cannabis and CBD products.
- Intense competition from established players in the pharmaceutical and consumer goods industries.
- Negative publicity or health concerns related to cannabis and CBD products.
- The company's negative profit margin indicates potential financial instability.
- The OTC Other tier carries higher regulatory and financial risks compared to major exchanges.
Growth Opportunities
- Expansion into New Geographies: Love Hemp Group Plc has the opportunity to expand its investments into new geographic markets, particularly in regions where cannabis regulations are becoming more favorable. This includes exploring opportunities in emerging markets in South America and Africa, where the cannabis industry is still in its early stages. The timeline for this expansion is ongoing, as the company continuously evaluates potential markets. The market size for cannabis in these regions is projected to grow significantly over the next decade, offering substantial growth potential.
- Product Diversification: Love Hemp Group Plc can drive growth by diversifying the product offerings of its portfolio companies. This includes expanding into new categories such as cannabis-infused beverages, edibles, and topical products. The market for these products is growing rapidly, driven by increasing consumer demand for alternative cannabis consumption methods. The timeline for this diversification is within the next 2-3 years, as the company works with its portfolio companies to develop and launch new products. The competitive advantage lies in Love Hemp's ability to identify and support innovative product development.
- Strategic Partnerships: Love Hemp Group Plc can leverage strategic partnerships to expand its reach and access new markets. This includes partnering with established pharmaceutical companies, retailers, and distributors to bring its portfolio companies' products to a wider audience. The timeline for these partnerships is ongoing, as the company actively seeks out potential collaborators. The market size for cannabis products sold through established channels is substantial, offering significant growth potential. The competitive advantage lies in Love Hemp's ability to forge mutually beneficial partnerships that leverage the strengths of both parties.
- Focus on Research and Development: Love Hemp Group Plc can invest in research and development to develop new and innovative cannabis-based products. This includes exploring the potential of new cannabinoids and developing novel delivery methods. The timeline for this R&D is long-term, as it requires significant investment and scientific expertise. The market for innovative cannabis products is potentially very large, as consumers are constantly seeking new and improved ways to experience the benefits of cannabis. The competitive advantage lies in Love Hemp's ability to identify and support cutting-edge research.
- Acquisition of Complementary Businesses: Love Hemp Group Plc can drive growth through the acquisition of complementary businesses in the cannabis industry. This includes acquiring companies with expertise in cultivation, manufacturing, distribution, or retail. The timeline for these acquisitions is opportunistic, as the company continuously evaluates potential targets. The market for cannabis businesses is consolidating, offering opportunities for Love Hemp to acquire valuable assets and expand its market share. The competitive advantage lies in Love Hemp's ability to identify and integrate strategic acquisitions.
Opportunities
- Increasing legalization and acceptance of cannabis and CBD products globally.
- Growing demand for CBD wellness products among consumers.
- Potential for strategic partnerships with established companies in the healthcare and retail sectors.
- Expansion into new geographic markets with favorable cannabis regulations.
Threats
- Regulatory uncertainty and changing laws regarding cannabis and CBD products.
- Intense competition from established players in the pharmaceutical and consumer goods industries.
- Potential for negative publicity or health concerns related to cannabis and CBD products.
- Economic downturns that could reduce consumer spending on wellness products.
Competitive Advantages
- Expertise in the CBD wellness and medicinal cannabis sectors.
- Established network of contacts and relationships within the industry.
- Flexible investment approach, including debt and equity financing.
- Geographic diversification across Europe, North America, and Asia.
About WRHLF
Love Hemp Group Plc, founded on January 30, 2019, and based in London, United Kingdom, operates as a private equity and venture capital firm. The firm strategically targets early-stage and mature companies, primarily within the Cannabidiol (CBD) wellness and medicinal cannabis sectors. Love Hemp Group Plc invests through various financial instruments, including debt and equity, in both quoted and unquoted securities. The firm's investment approach encompasses direct acquisitions of interests in companies, partnerships, joint ventures, direct interests in projects, and licensing arrangements. Love Hemp Group Plc focuses on companies involved in the cultivation of cannabis and hemp, the production of CBD oils, edibles, cosmetics, and capsules, as well as the manufacture and distribution of medicinal cannabis, hemp, and CBD products. The firm also invests in the pharmacology commercialization of medicinal cannabis, hemp, and CBD, professional prescription by practitioners, aftercare, statistical management, laboratory testing, and compliance within these sectors. Geographically, Love Hemp Group Plc targets investments in Europe, the United Kingdom, Germany, the Netherlands, North America, Australia, Japan, Thailand, Canada, Africa, South America, Israel, and Asia. The firm typically adopts a medium-to-long-term investment horizon, while also considering shorter-term opportunities. Love Hemp Group Plc seeks to acquire majority stakes in companies, but may also consider non-controlling positions.
What They Do
- Invests in early-stage and mature companies.
- Focuses on the Cannabidiol (CBD) wellness and medicinal cannabis sectors.
- Invests via debt or equity in quoted or unquoted securities.
- Acquires interests in companies, partnerships, and joint ventures.
- Invests in the cultivation, manufacture, and distribution of medicinal cannabis, hemp, and CBD products.
- Targets investments in Europe, North America, and Asia.
- Holds investments for the medium to long term.
- May acquire control or non-controlling positions in companies.
Business Model
- Love Hemp Group Plc generates revenue through capital appreciation from its investments in CBD and medicinal cannabis companies.
- The firm earns income from dividends or interest payments from its portfolio companies.
- Love Hemp Group Plc may also generate revenue through licensing arrangements related to cannabis and CBD products.
Industry Context
Love Hemp Group Plc operates within the rapidly expanding CBD wellness and medicinal cannabis industry. This sector is characterized by increasing consumer demand, evolving regulatory landscapes, and growing acceptance of cannabis-derived products for therapeutic and recreational use. The market is highly competitive, with numerous players ranging from small startups to established pharmaceutical companies. Love Hemp's strategy of investing across the value chain, from cultivation to distribution, positions it to capitalize on the industry's growth. However, the company faces challenges including regulatory uncertainty, competition from established players, and the need to navigate complex legal frameworks in different jurisdictions. Competitors include companies like Advanced Cannabis Technologies (ADVT), which are also involved in the cannabis sector.
Key Customers
- Early-stage and mature companies in the CBD wellness sector seeking capital.
- Companies in the medicinal cannabis industry requiring investment for growth and expansion.
- Businesses involved in the cultivation, manufacture, and distribution of hemp and CBD products.
Financials
Chart & Info
Love Hemp Group Plc (WRHLF) stock price: Price data unavailable
Latest News
No recent news available for WRHLF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WRHLF.
Price Targets
Wall Street price target analysis for WRHLF.
MoonshotScore
What does this score mean?
The MoonshotScore rates WRHLF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Antonio Luigi Calamita
CEO
Antonio Luigi Calamita serves as the CEO of Love Hemp Group Plc. His background encompasses experience in managing and directing companies, with a focus on strategic investments and growth initiatives. Calamita's expertise lies in identifying and capitalizing on opportunities within emerging markets, particularly in the healthcare and wellness sectors. He has a proven track record of building and scaling businesses, with a focus on innovation and customer satisfaction. His leadership is geared towards driving Love Hemp Group Plc's expansion and solidifying its position in the CBD and medicinal cannabis industries.
Track Record: Under Antonio Luigi Calamita's leadership, Love Hemp Group Plc has focused on strategic investments within the CBD and medicinal cannabis sectors. Key achievements include expanding the company's portfolio of investments across multiple geographies and product categories. Calamita has also overseen the development of strategic partnerships and initiatives aimed at driving revenue growth and increasing brand awareness. His focus on innovation and customer satisfaction has contributed to the company's growth and success.
WRHLF OTC Market Information
The OTC Other tier, where Love Hemp Group Plc trades, represents the lowest tier of the OTC market. Companies in this tier often have limited financial disclosure and may not meet minimum listing requirements. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, resulting in higher risks for investors. This tier typically includes companies that are distressed, in bankruptcy, or unwilling or unable to meet the listing standards of higher-tier exchanges. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in WRHLF.
- Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- The OTC Other tier carries higher regulatory and financial risks compared to major exchanges.
- The company's financial stability is uncertain due to its negative profit margin and limited operating history.
- Dependence on the evolving regulatory environment for cannabis and CBD products.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Research the company's regulatory compliance and legal standing.
- Check for any history of fraud or misconduct.
- Consult with a qualified financial advisor.
- Understand the risks associated with investing in OTC Other stocks.
- The company's focus on the high-growth CBD and medicinal cannabis sectors.
- The company's diversified investment approach across the value chain.
- The company's global presence with investments in multiple regions.
What Investors Ask About Love Hemp Group Plc (WRHLF) — Healthcare
What does Love Hemp Group Plc do?
Love Hemp Group Plc operates as a private equity and venture capital firm specializing in the Cannabidiol (CBD) wellness and medicinal cannabis sectors. The firm invests in early-stage and mature companies across the value chain, from cultivation to distribution. Love Hemp Group Plc provides capital and strategic support to its portfolio companies, aiming to drive growth and create value in the rapidly expanding cannabis market. The company's investments span across Europe, North America, and Asia, reflecting its global focus.
What do analysts say about WRHLF stock?
AI analysis is currently pending for WRHLF stock. Given its OTC Other listing and limited financial disclosure, analyst coverage is likely to be sparse. Investors should conduct their own thorough due diligence and consider the risks associated with investing in OTC stocks. Key valuation metrics, such as price-to-earnings ratio and price-to-sales ratio, may not be readily available or reliable due to the company's financial situation. Growth considerations should focus on the company's ability to execute its investment strategy and capitalize on the growth of the CBD and medicinal cannabis markets. No recommendation to buy or sell is expressed.
What are the main risks for WRHLF?
The main risks for Love Hemp Group Plc include regulatory uncertainty surrounding cannabis and CBD products, intense competition from established players, and potential negative publicity related to the industry. The company's negative profit margin and limited operating history also pose financial risks. As an OTC Other stock, WRHLF carries higher regulatory and financial risks compared to stocks listed on major exchanges. Investors should carefully consider these risks before investing in WRHLF.
What are the key factors to evaluate for WRHLF?
Love Hemp Group Plc (WRHLF) currently holds an AI score of 59/100, indicating moderate score. Key strength: Specialized focus on the high-growth CBD and medicinal cannabis sectors. Primary risk to monitor: Regulatory uncertainty and changing laws regarding cannabis and CBD products. This is not financial advice.
How frequently does WRHLF data refresh on this page?
WRHLF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven WRHLF's recent stock price performance?
Recent price movement in Love Hemp Group Plc (WRHLF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized focus on the high-growth CBD and medicinal cannabis sectors. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider WRHLF overvalued or undervalued right now?
Determining whether Love Hemp Group Plc (WRHLF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying WRHLF?
Before investing in Love Hemp Group Plc (WRHLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for OTC-traded companies.
- Financial data based on available information and may not be comprehensive.
- AI analysis pending.